Article
Bone metastasis unique plasma exosomal microRNA signature in non-small cell lung cancer
2020-04-22
Abstract excerpt
<h4>Background: </h4> 20–40% of lung cancer patients develop bone metastasis (BM) with significantly decreased overall survival. Currently, BM is mainly diagnosed by CT scan or MRI when symptom develops. Novel biomarkers with higher prediction value of BM are needed. Methods Prospective analysis was undertaken on non-small cell lung cancer (NSCLC) patients with (BM+) and without BM (BM-). Plasma exosomal RNA was...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2f5225f5-3620-54f7-9bd8-dca84f6f316b
- DOI
- 10.21203/rs.3.rs-23619/v1
